glycochenodeoxycholic acid has been researched along with Inflammation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, W; Gao, Z; He, W; Liu, J; Liu, S; Mao, S; Shi, X; Song, S; Wu, Y; Yan, L; Zhang, S | 1 |
| Banales, JM; Briz, O; Herraez, E; Lozano, E; Macias, RI; Marin, JJ; Monte, MJ; Sanchez-Vicente, L | 1 |
2 other study(ies) available for glycochenodeoxycholic acid and Inflammation
| Article | Year |
|---|---|
The gut microbiota metabolite glycochenodeoxycholate activates TFR-ACSL4-mediated ferroptosis to promote the development of environmental toxin-linked MAFLD.
Topics: Coenzyme A Ligases; Ferroptosis; Gastrointestinal Microbiome; Glycochenodeoxycholic Acid; Humans; Inflammation; Receptors, Transferrin | 2022 |
Cocarcinogenic effects of intrahepatic bile acid accumulation in cholangiocarcinoma development.
Topics: Animals; Apoptosis; Bile Acids and Salts; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers, Tumor; Cell Proliferation; Cells, Cultured; Cholangiocarcinoma; Cholestasis; Cholic Acids; Cisplatin; Cocarcinogenesis; Cross-Linking Reagents; DNA Damage; Glycochenodeoxycholic Acid; Hepatocytes; Inflammation; Interleukin-6; Liver; Liver Neoplasms; Male; Promoter Regions, Genetic; Rats; Rats, Wistar; Rec A Recombinases; Receptor, ErbB-2; Receptors, Cytoplasmic and Nuclear; SOS Response, Genetics; Thioacetamide | 2014 |